Herberto Dhanis Profile picture
May 12 8 tweets 4 min read Twitter logo Read on Twitter
I always knew there were diseases we had no cure for, but developing #LongCovid opened my eyes to a world of suffering I had no idea existed. I didn’t know what #MECFS was, and with this name, I could have never imagined such suffering.

#MEAwarenessDay
#MECFS in its very severe form is probably one of the most debilitating diseases in the world. It is particularly cruel because it considerably limits energy and “punishes” those who step out of their energy limits by worsening symptoms, sometimes permanently
Doctors and researchers who care, have compared it to late stage AIDS or kidney failure, in which the patients barely exist and typically die after ~ one month. However, patients w/ very severe #MECFS live permanently like this, and the disease has been coined “the living death”
I share below the brave video-project of a patient documenting his day-to-day life. Do to the severity of his illness @AnilvanderZee has been living mostly in isolation for 10 years. Sobering and extremely courageous report.

Finally, I never expected something like this to exist, but what I expected even less is to learn how it has been ignored by the medical/research community. How these patients have been psychologised in the worst way possible, in face of such a debilitating disease.
One field in particular, too close to mine, has actively participated in the oppression and psychologization of these patients. It’s impossible for any field to say, “in the absence of any observable structural or organic dysfunction". We don't know about so many...
potential dysfunctions (yet). That's why we have research! It's time for everyone to open their eyes to post-viral conditions like #MECFS. These patients have waited for treatments for far too long. No more psychologisation, no more dismissal.

#MillionsMissing #MEAwarenessDay
If #LongCovid brought anything good, I hope it's research, attention and hopefully-enough treatments for both these conditions!

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Herberto Dhanis

Herberto Dhanis Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @HerbertoDhanis

Sep 24, 2022
We just got another great paper by the team of @Dr_B_Hohberger. The correlations they have been showing between retinal vascular density and LC are impressive. Absolutely recommend people read this and see it together with other relevant publications

medrxiv.org/content/10.110…
The opinion of her team is that these findings reflect widespread impairments of microcirculation (the retina is just a window into the body). Is there compelling evidence that this is the case? Yes. See for example:

doi.org/10.1007/s10456…
More than that there are numerous papers showing constant endothelial damage. For example:

onlinelibrary.wiley.com/doi/full/10.11…

If this doesn't convince you, there are autopsy brain studies w/converging evidence, and studies w/auto-immune dysfunction targeting the endothelium/vasculature.
Read 5 tweets
Aug 29, 2022
There’s been a lot of talk (and evidence of course) about neurological dysfunction and neuro-inflammation in #LongCovid. So I though I would do a thread on an upcoming phase II RCT with Temelimab in LC patients with neuropsychiatric symptoms. 1/14
The trial is lead by @GeneuroO and the Hospital of Geneva @Hopitaux_unige, 1st to have an LC clinic I think + Swiss Gov granted 6.7 million CHF. To be clear I am not involved in this I just thought to share. I learned about it through @LongCovidCH some time ago. Let's start 2/14
Temelimab is a monoclonal antibody (Ig G4) developed for Multiple Sclerosis and ALS that targets the HERV-W envelope protein. It has shown success in treating progressive MS and it has anti-neurodegenerative action 3/14

journals.sagepub.com/doi/10.1177/13…
Read 16 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us on Twitter!

:(